EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pan‐cancer analysis of SERPINE1 with a concentration on immune therapeutic and prognostic in gastric cancer

Yuming Ju iD, Zeshen Wang, Qiancheng Wang, Shiyang Jin, Pengcheng Sun, Yuzhe Wei, Guanyu Zhu, Kuan Wang

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.18579 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Yuming Ju und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Harbin Medical University Cancer Hospital, Harbin, China. Hauptthemen laut MEDLINE: Plasminogen Activator Inhibitor 1, Stomach Neoplasms, Gene Expression Regulation, Neoplastic, Cell Proliferation. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The serine protease inhibitor clade E member 1 (SERPINE1) is a key modulator of the plasminogen/plasminase system and has been demonstrated to promote tumor progression and metastasis in various tumours. However, although much literature has explored the cancer‐promoting mechanism of SERPINE1, the pan‐cancer analyses of its predictive value and immune response remain unexplored. The differential expression, and survival analysis of SERPINE1 expression in multiple cancers were analysed using The Cancer Genome Atlas and Genotype‐Tissue Expression database. Kaplan–Meier (K–M) plotter and survival data analysis were used to analyze the prognostic value of SERPINE1 expression, including overall survival (OS), disease‐specific survival, disease‐free interval and progression‐free interval and investigated the relationship of SERPINE1 expression with microsatellite instability. We further analysed the correlation between the expression of SERPINE1 and immune infiltration. The Kyoto Encyclopaedia of Genes and Genomes pathway was used for enrichment analysis, and the Gene Set Enrichment Analysis (GSEA) database was used to perform pathway analysis. Finally, in vitro experiments demonstrated that knockdown or overexpression of SERPINE1 could alter the proliferation and migration of gastric cancer (GC) cells. The results indicated that SERPINE1 expression levels different significantly between cancer and normal tissues, meanwhile, it was highly expressed in various cancers. By analysing online data, it has been observed that the gene SERPINE1 exhibits heightened expression levels across a variety of human cancers, significantly impacting patient survival rates. Notably, the presence of SERPINE1 was strongly associated with decrease OS and disease‐free survival in individuals diagnosed with GC. Furthermore, an observed link indicates that higher levels of SERPINE expression are associated with increased infiltration of immune cells in GC. Finally, in vitro experiments showed that knockdown or overexpression of SERPINE1 inhibited the growth, and migration, of GC cells. SERPINE1expression potentially represents a novel prognostic biomarker due to its significant association with immune cell infiltration in GC. This study shows that SERPINE1 is an oncogene that participates in regulating the immune infiltration and affecting the prognosis of patients in multiple cancers, especially in GC. These findings underscore the importance of further investigating the role of SERPINE1 in cancer progression and offer a promising direction for the development of new therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasminogen Activator Inhibitor 1Stomach NeoplasmsGene Expression Regulation, NeoplasticCell ProliferationHumansPrognosisCell Line, TumorBiomarkers, TumorCell MovementKaplan-Meier EstimateMicrosatellite Instability

Stichwörter der Autor:innen

SERPINE1bioinformaticsimmune infiltratingpan‐cancer analysis

Substanzen

Plasminogen Activator Inhibitor 1SERPINE1 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, Harbin Medical University Cancer Hospital, Harbin, China.

ORCID-Profile: Yuming Ju

Zitieren

APA

Ju, Y., Wang, Z., Wang, Q., Jin, S., Sun, P., Wei, Y., Zhu, G., & Wang, K. (2024). Pan‐cancer analysis of SERPINE1 with a concentration on immune therapeutic and prognostic in gastric cancer. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18579

Vancouver

Ju Y, Wang Z, Wang Q, Jin S, Sun P, Wei Y, et al. Pan‐cancer analysis of SERPINE1 with a concentration on immune therapeutic and prognostic in gastric cancer. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18579

BibTeX
@article{Ju2024,
  author = {Ju, Yuming and Wang, Zeshen and Wang, Qiancheng and Jin, Shiyang and Sun, Pengcheng and Wei, Yuzhe and Zhu, Guanyu and Wang, Kuan},
  title = {Pan‐cancer analysis of SERPINE1 with a concentration on immune therapeutic and prognostic in gastric cancer},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.18579}
}
Kostenlos starten →